Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study
- 12 October 2024
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 191, 143-149
Abstract
No abstract availableKeywords
Funding Information
- NIH (CA016672)
This publication has 22 references indexed in Scilit:
- Extrauterine endometrial stromal sarcoma: A systematic review and outcome analysisAnnals of Diagnostic Pathology, 2022
- Cancer-related loneliness mediates the relationships between social constraints and symptoms among cancer patientsJournal of Behavioral Medicine, 2017
- Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trialsEuropean Journal of Cancer, 2015
- Staging of uterine sarcomasBest Practice & Research Clinical Obstetrics & Gynaecology, 2011
- Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic rolesGynecologic Oncology, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989–2007Journal of Cancer Research and Clinical Oncology, 2008
- Expression of androgen receptors in benign and malignant endometrial stromal neoplasmsVirchows Archiv, 2004
- Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17)Cancer Genetics and Cytogenetics, 2003
- Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? a retrospective study of prognostic factors of 60 patients stratified by stagesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002